Dec
Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
DESIGNATION STATEMENT
Physicians' Education Resource®, LLC designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 CreditTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity
Atopic dermatitis is a chronic, relapsing skin disease which places a significant burden on patients, resulting in a lower quality of life. In moderate-to-severe disease, patients also suffer from high levels of psychological distress, increased prevalence of psychiatric diseases, and increased risk of cardiometabolic comorbidities. During this Medical Crossfire®, dermatology experts will engage in a multidisciplinary roundtable moderated by a family physician with the additional perspective of a patient’s treatment journey as video clips throughout the discussion. Topics covered include disease manifestations, diagnostic criteria, pathophysiology of moderate-to-severe atopic dermatitis and treatment approaches with both current and new and emerging therapies. Faculty will emphasize the importance of individualized treatment plans in a patient-centered approach.
INTENDED AUDIENCE
This activity is directed to dermatologists, allergists, immunologists, rheumatologists, primary care physicians, researchers; other healthcare professionals interested in the treatment of Atopic Dermatitis are invited to participate.
EDUCATIONAL OBJECTIVES
After completing this activity, clinicians should be better able to:
Outline the burden of atopic dermatitis (AD) on patients.
Discuss the most recent information on the epidemiology and pathogenesis of AD, and how this is likely to affect the management of patients with AD.
Analyze how older and newer therapies fit into the AD treatment paradigm.
Clarify how a multidisciplinary, patient-centered, approach to care may improve patient outcomes in AD.
CONFLICT OF INTEREST DISCLOSURE POLICY
As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI. Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.
Paul P. Doghramji, MD, FAAFP
Attending Physician, Collegeville Family Practice
Medical Director, Health Services, Ursinus College, Collegeville, PA
Cofounder, Brookside Family Practice and Pediatrics
Assistant Medical Director, Health Services, Hill School, Pottstown, PA
Dr. Doghramji has no relevant financial relationships with commercial interests.
Chair
Peter Lio, MD
Assistant Clinical Professor
Dermatology and Pediatrics
Northwestern University, Feinberg School of Medicine
Chicago, IL
Dr. Lio discloses the following:
Grant/Research Support: AOBIOME, Pierre-Fabre
Consultant: AOBiome, Anacor, L’Oreal, Pfizer, Regeneron/Sanofi, Theraplex, Valeant
Speakers Bureau: L’Oreal, Pfizer, Regeneron/Sanofi
Christine Go, MMS, PA-C
Leone Dermatology
Arlington Heights, IL
Ms. Go has no relevant financial relationships with commercial interests.
Pamela P. Fantus, RN, MSN
Patient
Ms. Fantus has no relevant financial relationships with commercial interests
USD
We don’t accept Online Abstracts
Contact No.: 201.799.4800
Email: myCME.Support@haymarketmedical.com
Contact No.: 201.799.4800
Email: myCME.Support@haymarketmedical.com